Related Experiment Video
Updated: Aug 19, 2026
Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
Published on: May 2, 2025
Molecular pathogenesis of childhood brain tumors
Torsten Pietsch1, Michael D Taylor, James T Rutka
1Department of Neuropathology, University of Bonn Medical Center, Bonn, Germany.
Abstract:
In the last decade, the molecular biology revolution has advanced considerably. These advances have enhanced our understanding of the genetic underpinnings of human brain tumors in general, and pediatric brain tumors in particular. We now know that many pediatric brain tumors arise from disturbances in developmentally regulated signaling pathways. The medulloblastoma, a tumor in which the developmental Hedgehog and WNT pathways have gone awry, is a prime example of this. New techniques in genetic engineering have allowed for the creation of sophisticated mouse models of brain tumors that recapitulate the human disease. Many laboratories are now using cDNA microarrays to study the expression level of thousands of genes that may be aberrantly expressed in brain tumors when compared to normal control cells. In the next decade, the use of several new molecular techniques to establish brain tumor diagnoses will likely become standard tools in the diagnostics and treatment stratification of children with central nervous system tumors.
Insights
Advances in molecular biology have improved understanding of pediatric brain tumors, revealing links to developmental signaling pathways. New techniques will enhance diagnosis and treatment stratification for these central nervous system tumors.
Area of Science:
- Molecular biology
- Genetics
- Pediatric oncology
Background:
- The molecular biology revolution has significantly advanced our understanding of human brain tumors, especially in children.
- Pediatric brain tumors often originate from disruptions in developmentally regulated signaling pathways, such as the Hedgehog and WNT pathways in medulloblastoma.
- Sophisticated mouse models have been developed using genetic engineering to better recapitulate human brain tumors.
Purpose of the Study:
- To highlight the impact of recent molecular biology advancements on understanding pediatric brain tumors.
- To discuss the role of developmental signaling pathways in the etiology of these tumors.
- To explore the potential of emerging molecular techniques in future diagnostics and treatment.
Main Methods:
- Review of recent advancements in molecular biology and genetic engineering.
- Analysis of gene expression using cDNA microarrays to identify aberrant gene expression in brain tumors.
- Examination of developmental signaling pathways implicated in pediatric brain tumor formation.
Main Results:
- Identification of disturbed developmental signaling pathways as a key factor in pediatric brain tumor development.
- Demonstration that sophisticated mouse models can accurately mimic human pediatric brain tumors.
- Observation of aberrant gene expression in brain tumors compared to normal cells via cDNA microarrays.
Conclusions:
- Molecular insights have deepened the understanding of pediatric brain tumor genetics.
- New molecular techniques are poised to become standard tools for diagnosing and stratifying treatment for pediatric central nervous system tumors.
- Targeting developmental pathways presents a potential avenue for future therapeutic strategies.
Related Concept Videos
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:26Bacterial Meningitis II: Pathophysiology
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...